Abstract
Purpose This single-center, retrospective cohort study investigated the effects of timing of initiating home neuropsychiatric medications (NPMs) on sedation-related outcomes. Materials and methods Subjects included adult medical intensive care unit (MICU) patients who had an NPM on their admission medication list; intubated before or on arrival to the intensive care unit (ICU); and were on benzodiazepine-based sedation. The intervention assessed was the timing of the initiation of home NPMs: early (≤ 5 days) vs. late (> 5 days) into the ICU stay. Results There were 56 and 53 patients in the early and late restart groups, respectively. Early cohort patients maintained a median daily RASS of − 1.5, while late cohort patients had a median daily RASS of − 2.0 (p = 0.02). The effect was driven by the subgroup of patients on home anti-depressant therapy who were restarted early on these agents. The early restart group had a higher percentage of days with RASS scores within goal (p = 0.01) and less delirium (p = 0.02). Early restarting of home NPMs was associated with a non-significant decrease in ventilator days compared with late restarting (p = 0.11). Conclusions Restarting home NPMs was associated with lighter sedation levels and less delirium.
Original language | English |
---|---|
Pages (from-to) | 102-107 |
Number of pages | 6 |
Journal | Journal of Critical Care |
Volume | 43 |
DOIs | |
State | Published - Feb 2018 |
Bibliographical note
Funding Information:Funding: The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health , through grant number UL1TR001998 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Publisher Copyright:
© 2017 Elsevier Inc.
Keywords
- Antidepressants
- Antipsychotics
- Benzodiazepines
- Gabapentinoids
- Medication reconciliation
- Sedation
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine